Abstract Biofluids are an abundant source of readily accessible biologic information. In the young, biofluids such as saliva, stool, and urine remain an underinvestigated resource of biomarker discovery, which is less invasive and easily collected in outpatient settings. In this perspective, we summarise the current standing of biomarker mining in young cardiovascular patients, presenting advancements in new technologies that can be leveraged in these low-input samples. We provide our perspective on future work and offer examples of the potential utility of these biofluids for non-invasive and remote and longitudinal monitoring in paediatric patients.
Delany et al. (Tue,) studied this question.